Pharmacological management of SAPHO syndrome

Bibliography

• CHAMOT AM, BENHAMOU CL, KAHN MF, BERANECK L, KAPLAN G, PROST A: Le Syndrome Acne Pustolose Hyperostose Ostéite (SAPHO). Resultats d’une enquete nationale. 85 observations. Rev. Rhum. Mal. Osteoartic. (1987) 54(3):187-196.
   Google Scholar
• KAHN MF: Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. Curr. Opin. Rheumatol. (1993) 5(4):378-384.
   Web of Science ®Google Scholar
• VEALE D, ROGERS S, FITZGERALD O: Classification of clinical subset in psoriatic arthritis. Br. J. Rheumatol. (1994) 33(2):133-138.
   Web of Science ®Google Scholar
• CUELLAR ML, SIVEIRA LH, ESPINOZA LR: Recent developments in psoriatic arthritis. Curr. Opin. Rheumatol. (1994) 6(4):428-435.
   Google Scholar
• DOUGADOS M, VAN DER LINDEN S, JUHLIN R et al.: The European Spondylarthropathy Study Group for the classification of spondylarthropathy. Arthritis Rheum. (1991) 34(10):1218-1227.
   PubMed Web of Science ®Google Scholar
• KAHN MF, KHAN MA: The SAPHO syndrome. Baillieres. Clin. Rheumatol. (1994) 8(2):833-862.
   Google Scholar
• KIRCHHOFF T, MERKESDAL S, ROSENTHAL H et al.: Diagnostic mangement of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up. Eur. Radiol. (2003) 13(10):2304-2308.
   Google Scholar
• GAMBLE JG, RINSKY LA: Chronic recurrent multifocal osteomyelitis: a distinct clinical entity. J. Pediatr. Ortop. (1986) 6(5):579-584.
   Google Scholar
• JURIK AJ: Chronic recurrent multifocal osteomyelits. Semin. Musculoskelet. Radiol. (2004) 8(3):243-253.
   Google Scholar
• SCHILLING F, KESSLER S: Das SAPHO-syndrom: Klinisch-rheumatologische und radiologische differenzierung und Klassifizierung eines Krankengutes von 86 Fällen. Z. Rheumatol. (2000) 59(5):352-353.
   Google Scholar
• MANSON D, WILMOT DM, KING S, LAXER RM: Physeal involvement in chronic recurrent multifocal osteomyelitis. Pediatr. Radiol. (1989) 20(1-2):76-79.
   Google Scholar
• CHOW LT, GRIFFITH JF, KUMTA SM, LEUNG PC: Chronic recurrent multifocal osteomyelitis. a great clinical and radiologic mimic in need of recognition by the pathologist. APMIS (1999) 107(4):369-379.
   PubMed Web of Science ®Google Scholar
• REITH JD, BAUER TW, SCILS JP: Osseous manifestations of SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome. Am. J. Surg. Pathol. (1996) 20(11):1368-1377.
   Web of Science ®Google Scholar
• SCARPA R, MATHIEU A: Psoriatic arthritis: evolving concepts. Curr. Opin. Rheumatol. (2000) 12(4):274-280.
   Web of Science ®Google Scholar
• TOUSSIROT E, DUPOND JL, WENDLING D: Spondylodiscitis in SAPHO syndrome: a series of eight cases. Ann. Rheum. Dis. (1997) 56(1):52-58
   Google Scholar
• HAYEM G, BOUCHAUD-CHABOT A, BENALI K et al.: SAPHO syndrome: a long-term follow-up study of 120 cases. Semin. Arthritis Rheum. (1999) 29(3):159-171.
   Google Scholar
• VAN DOORNUM S, BARRACLOUGH D, McCOLL G, WICKS I: SAPHO: rare or just nor recognized? Semin. Arthritis Rheum. (2000) 30(1):70-77.
   Google Scholar
• HANDRICK W, HÖRMANN D, VOPPMANN A et al.: Chronic recurrent multifocal osteomyelitis – report of eight patients. Pediatr. Surg. Int. (1998) 14(3):195-198.
   Google Scholar
• KAHN MF, CHAMOT AM: SAPHO syndrome. Rheum. Dis. Clin. North Am. (1992) 18(4):225-246.
   Google Scholar
• SCARPATO S, TIRRI E: Successful treatment of SAPHO syndrome with leflunomide. Report of two cases. Clin. Exp. Rheumatol. (2005) 23(5):731.
   Google Scholar
• EDLUND E, JOHNSSON U, LIDGREN L et al.: Palmoplanatar pustolosis and sternocostoclavicular arthro-osteitis. Ann. Rheum. Dis. (1988) 47(10):809-815.
   PubMed Web of Science ®Google Scholar
• KOTILAINEN P, MERILAHTI-PALO R, LEHTONEN O et al.: Propionobacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J. Rheumatol. (1996) 23(7):1302-1304.
   Google Scholar
• BALLARA SC, SIRAJ QH, MAINI RN, VENABLES PJ: Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum. (1999) 42(4):819-821.
   PubMed Web of Science ®Google Scholar
• HAGEMANN D, PFAFFENBACH B, SCHMID G, ADAMEK RJ: Wirbelkörperdestruktionen mit massiven schmerzen durch das SAPHO-syndrom. Dtsch. Med. Wschr. (1999) 124(5):114-118.
   PubMed Web of Science ®Google Scholar
• SCHILLING F, WAGNER AD: Azithromycin: eine anti-inflammatorische wirksamkeit im einsatz bei der chronischen rekurrierenden multifokalen osteomyelitis? Eine vorläufige mitteilung. Z. Rheumatol. (2000) 59(5):352-353.
   Google Scholar
• DONELLY S, DOYLE DV: Chronic diffuse sclerosing osteomyelitis of the humerus. Novel treatment with calcitonin. J. Rheumatol. (1993) 20(6):1073-1076.
   Google Scholar
• MISAKI T, DOKOS S, MORI E: Calcitonin treatment for intersternoclavicular ossification: clinical experience in two cases. Ann. Rheum. Dis. (1991) 50(11):813-816.
   PubMed Web of Science ®Google Scholar
• SAYAG-BOUKRIS V, LAOUSSADI S, CORMIER C, LAROCHE F, MENKES CJ, KAHAN A: Efficacy of pamidronate in the treatment of SAPHO syndrome. Arthritis Rheum. (1998) 41:S114 (Supplement).
   Google Scholar
• SOUBRIER M, DUBOST JJ, RISTORI JM, SAUVEZIE B, BUSSIERE JL: Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo. (2001) 92(6):637-640.
   Google Scholar
• MARSHALL H, BROMILOW J, THOMAS AL, ARDEN NK: Pamidronate: a novel treatment for SAPHO syndrome? Rheumatology (Oxford) (2002) 41(2):231-233.
   PubMed Web of Science ®Google Scholar
• GUIGNARD S, JOB-DESLANDRE C, SAYAG-BOUKRIS V, KAHAN A: Pamidronate treatment in SAPHO syndrome. Joint Bone Spine (2002) 69(4):392-396.
   PubMed Web of Science ®Google Scholar
• COURTNEY PA, HOSKING DJ, FAIRBAIRN KJ, DEIGHTON CM: Treatment of SAPHO with pamidronate. Rheumatology (Oxford) (2002) 41(10):1196-1198.
   PubMed Web of Science ®Google Scholar
• CRISP AJ: Pamidronate for SAPHO syndrome. Rheumatology (Oxford) (2003) 42(3):491.
   PubMed Web of Science ®Google Scholar
• AMITAL H, APPLBAUM YH, AAMAR S, DANIEL N, RUBINOW A: SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) (2004) 43(5):658-661.
   PubMed Web of Science ®Google Scholar
• KERRISON C, DAVIDSON JE, CLEARY AG, BERESFORD MW: Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford) (2004) 43(10):1246-1251.
   PubMed Web of Science ®Google Scholar
• VALLS-ROC M, SANMARTI M, SALLES M, HOLGADO S, OLIVE A: SAPHO syndrome and pamidronate revisited. Rheumatology (Oxford) (2005) 44(3):137.
   PubMed Web of Science ®Google Scholar
• SOLAU-GERVAIS E, SOUBRIER M, GEROT I et al.: The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology (Oxford) (2006) 45(3):339-342.
   PubMed Web of Science ®Google Scholar
• TEHRANI R: SAPHO syndrome treated with pamidronate. Indian J. Dermatol. Venereol. Leprol. (2005) 71(4):273-275.
   Google Scholar
• KOPTERIDES P, PIKAZIS D, KOUFOS C: Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum. (2004) 50(9):2970-2973.
   PubMed Web of Science ®Google Scholar
• PENNANEN N, LAPINJOKI S, URTTI A, MONKKONEN J: Effect of liposomal and free bisphosphonates on the IL-1β, IL-6 and TNF-α secretion form RAW 264 cells in vitro. Pharm. Res. (1995) 12(6):916-922.
   Google Scholar
• MACKSYMOWYCH WP, JHANGRI GS, LECLERCQ S, SKEITH K, YAN A, RUSSEL AS: An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J. Rheumatol. (1998) 25(4):714-717.
   Google Scholar
• MACKSYMOWYCH WP, LAMBERT R, JHANGRI GS et al.: Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J. Rheumatol. (2001) 28(1):144-155.
   Google Scholar
• MACKSYMOWYCH WP, JHANGRI GS, FITZGERALD AA et al.: A six-month randomized, controlled, double-blinded, dose response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of NSAID-refractory ankylosing spondylitis. Arthritis Rheum. (2002) 46(3):766-773.
   PubMed Web of Science ®Google Scholar
• BRAUN J, BARALIAKOS X, BRANDT J, SIEPER J: Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Scand. J. Rheumatol. (2005) 34(3):178-190.
   PubMed Web of Science ®Google Scholar
• OLIVIERI I, PADULA A, CIANCIO G, SALVARANI C, NICCOLI L, CANTINI F: Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann. Rheum. Dis. (2002) 61(4):375-376.
   PubMed Web of Science ®Google Scholar
• OLIVIERI I, PADULA A, CIANCIO G, SALVARANI C, NICCOLI L, CANTINI F: Persistent efficacy of tumor necrosis factor α blockage therapy in SAPHO syndrome: comment on the article by Wagner et al. Arthritis Rheum. (2003) 48(5):1467.
   PubMed Web of Science ®Google Scholar
• WAGNER AD, ANDRESEN J, JEDRO MC, HULSEMANN JL, ZEIDLER H: Sustained response to tumor necrosis factor α-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum. (2002) 46(7):1965-1968.
   PubMed Web of Science ®Google Scholar
• IQBAL M, KOLODNEY MS: Acne fulminans with synovitis-acne- pustolosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J. Am. Acad. Dermatol. (2005) 52(5 Suppl. 1):S118-S120.
   PubMed Web of Science ®Google Scholar
• MASSARA A, CAVAZZINI PL, TROTTA F: In SAPHO syndrome anti-TNF-α therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) (2006) 45(6):730-733.
   PubMed Web of Science ®Google Scholar
• DEUTSCHMANN A, MACHE CJ, BODO K, ZEBEDIN D, RING E: Successful treatment of chrinic recurrent multifocal osteomyelitis with tumor necrosis factor-α blockage. Pediatrics (2005) 116(5):1231-1233.
   PubMed Web of Science ®Google Scholar
• CARPENTER E, JACKSON MA, FRIESEN CA, SCARBROUGH M, ROBERTS CC: Crohn’s-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J. Pediatr. (2004) 144(4):541-544.
   Google Scholar